Cargando…
The Uprising of Mitochondrial DNA Biomarker in Cancer
Cancer is a heterogeneous group of diseases, the progression of which demands an accumulation of genetic mutations and epigenetic alterations of the human nuclear genome or possibly in the mitochondrial genome as well. Despite modern diagnostic and therapeutic approaches to battle cancer, there are...
Autores principales: | Mohd Khair, Siti Zulaikha Nashwa, Abd Radzak, Siti Muslihah, Mohamed Yusoff, Abdul Aziz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302403/ https://www.ncbi.nlm.nih.gov/pubmed/34326906 http://dx.doi.org/10.1155/2021/7675269 |
Ejemplares similares
-
Research highlights on contributions of mitochondrial DNA microsatellite instability in solid cancers – an overview
por: Yusoff, Abdul Aziz Mohamed, et al.
Publicado: (2022) -
A comprehensive overview of mitochondrial DNA 4977-bp deletion in cancer studies
por: Yusoff, Abdul Aziz Mohamed, et al.
Publicado: (2019) -
Insights regarding mitochondrial DNA copy number alterations in human cancer
por: Abd Radzak, Siti Muslihah, et al.
Publicado: (2022) -
Prevalence of mitochondrial DNA common deletion in patients with gliomas and meningiomas: A first report from a Malaysian study group
por: Mohamed Yusoff, Abdul Aziz, et al.
Publicado: (2020) -
Detection of FZD4, LRP5 and TSPAN12 Genes Variants in Malay Premature Babies with Retinopathy of Prematurity
por: Mohd Khair, Siti Zulaikha Nashwa, et al.
Publicado: (2019)